These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 16397213)

  • 1. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.
    Elstrodt F; Hollestelle A; Nagel JH; Gorin M; Wasielewski M; van den Ouweland A; Merajver SD; Ethier SP; Schutte M
    Cancer Res; 2006 Jan; 66(1):41-5. PubMed ID: 16397213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline BRCA1 mutation and survival analysis in familial breast cancer patients in Kerala; South India.
    Vinodkumar B; Syamala V; Abraham EK; Balakrishnan R; Ankathil R
    J Exp Clin Cancer Res; 2007 Sep; 26(3):329-36. PubMed ID: 17987791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines.
    Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
    Anticancer Res; 2010 Jun; 30(6):2049-54. PubMed ID: 20651350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
    Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M
    Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.
    Quaresima B; Romeo F; Faniello MC; Di Sanzo M; Liu CG; Lavecchia A; Taccioli C; Gaudio E; Baudi F; Trapasso F; Croce CM; Cuda G; Costanzo F
    Clin Cancer Res; 2008 Nov; 14(21):6797-803. PubMed ID: 18980973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.
    Tomlinson GE; Chen TT; Stastny VA; Virmani AK; Spillman MA; Tonk V; Blum JL; Schneider NR; Wistuba II; Shay JW; Minna JD; Gazdar AF
    Cancer Res; 1998 Aug; 58(15):3237-42. PubMed ID: 9699648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription.
    Somasundaram K
    J Cell Biochem; 2003 Apr; 88(6):1084-91. PubMed ID: 12647291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BRCA1 1100delAT is a recurrent mutation in Chinese women with familial breast cancer].
    Li WF; Hu Z; Zhang B; Cao MZ; Wang YS; Liu XY; Zhao L; Liu YB; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):76-80. PubMed ID: 17418009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
    Li WF; Hu Z; Rao NY; Song CG; Zhang B; Cao MZ; Su FX; Wang YS; He PQ; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Liu XY; Zhou J; Wang L; Zhao L; Liu YB; Yuan WT; Yang L; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2008 Jul; 110(1):99-109. PubMed ID: 17851763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
    DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
    Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
    Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
    Konstantopoulou I; Rampias T; Ladopoulou A; Koutsodontis G; Armaou S; Anagnostopoulos T; Nikolopoulos G; Kamakari S; Nounesis G; Stylianakis A; Karanikiotis C; Razis E; Gogas H; Keramopoulos A; Gaki V; Markopoulos C; Skarlos D; Pandis N; Bei T; Arzimanoglou I; Fountzilas G; Yannoukakos D
    Breast Cancer Res Treat; 2008 Feb; 107(3):431-41. PubMed ID: 17453335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus.
    Loizidou M; Marcou Y; Anastasiadou V; Newbold R; Hadjisavvas A; Kyriacou K
    Clin Genet; 2007 Feb; 71(2):165-70. PubMed ID: 17250666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of BAF57 mutations in human breast cancer cell lines.
    Kiskinis E; García-Pedrero JM; Villaronga MA; Parker MG; Belandia B
    Breast Cancer Res Treat; 2006 Jul; 98(2):191-8. PubMed ID: 16538531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
    Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
    Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.